The Ghana Health Service (GHS) has made a significant move in public health by incorporating the Human Papillomavirus (HPV) vaccine into the country’s routine immunization schedule. This initiative comes on the heels of a nationwide vaccination campaign that took place in September 2025.
Starting in January 2026, the GHS will ensure that all girls aged 9 to 14, who missed the opportunity to receive the vaccine during the previous campaign, will have access to vaccinations through both school health services and out-of-school health programs. This decision was announced in a press release from Wilhemina Duah Morttey, the Municipal Director of Health Services in Tarkwa Nsuaem, and shared with the Ghana News Agency.
The primary aim of this vaccination initiative is to significantly reduce the incidence of cervical cancer, which is a leading cause of cancer-related deaths among women in Ghana. According to the World Health Organization (WHO), cervical cancer ranks as the fourth most common type of cancer in women globally, resulting in around 660,000 new cases and approximately 350,000 deaths in 2022 alone. Alarmingly, 94% of cervical cancer fatalities occur in low- and middle-income nations, including Ghana.
The press statement elaborated on the current lack of effective treatment options for cervical cancer, emphasizing that vaccination is a critical preventative measure. HPV is a viral infection predominantly affecting women and is transmitted through various forms of sexual contact, as well as through skin-to-skin interactions and bodily fluids. Many individuals may carry the virus asymptomatically, making awareness and vaccination all the more vital.
The introduction of the HPV vaccine into Ghana’s health program represents a proactive step toward safeguarding the health of future generations and combating the rising threat of cervical cancer.
